THE LIFE CYCLE MANAGEMENT COMPANY Trademark

Trademark Overview


On Friday, January 28, 2022, a trademark application was filed for THE LIFE CYCLE MANAGEMENT COMPANY with the United States Patent and Trademark Office. The USPTO has given the THE LIFE CYCLE MANAGEMENT COMPANY trademark a serial number of 79336910. The federal status of this trademark filing is REGISTERED as of Tuesday, July 18, 2023. This trademark is owned by Atnahs Pharma UK Limited. The THE LIFE CYCLE MANAGEMENT COMPANY trademark is filed in the Pharmaceutical Products, Advertising and Business and Retail Services categories with the following description:

Pharmaceutical products and preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical products and preparations, namely, antivirals, analgesic, antipyretic and anti-inflammatory products and preparations; Pharmaceutical products and preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical products and preparations for the prevention and treatment of cancer; cardiovascular pharmaceutical preparations; sanitary preparations for medical purposes

Retail store and wholesale store services featuring pharmaceutical products and preparations
the life cycle management company

General Information


Serial Number79336910
Word MarkTHE LIFE CYCLE MANAGEMENT COMPANY
Filing DateFriday, January 28, 2022
Status700 - REGISTERED
Status DateTuesday, July 18, 2023
Registration Number7109767
Registration DateTuesday, July 18, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 2, 2023

Trademark Statements


Goods and ServicesPharmaceutical products and preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical products and preparations, namely, antivirals, analgesic, antipyretic and anti-inflammatory products and preparations; Pharmaceutical products and preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical products and preparations for the prevention and treatment of cancer; cardiovascular pharmaceutical preparations; sanitary preparations for medical purposes
Goods and ServicesRetail store and wholesale store services featuring pharmaceutical products and preparations
Disclaimer with Predetermined Text"COMPANY"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 4, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, April 4, 2022
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAtnahs Pharma UK Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameAtnahs Pharma UK Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameAtnahs Pharma UK Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Sunday, November 12, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, October 19, 2023FINAL DISPOSITION NOTICE SENT TO IB
Thursday, October 19, 2023FINAL DISPOSITION PROCESSED
Wednesday, October 18, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 18, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, July 18, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, May 2, 2023PUBLISHED FOR OPPOSITION
Monday, May 1, 2023NOTIFICATION PROCESSED BY IB
Sunday, April 16, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Wednesday, April 12, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 12, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, April 12, 2023NOTICE OF PUBLICATION
Monday, March 27, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 23, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 22, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 22, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 7, 2023REFUSAL PROCESSED BY IB
Thursday, January 19, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, January 19, 2023REFUSAL PROCESSED BY MPU
Friday, November 11, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, November 10, 2022NON-FINAL ACTION WRITTEN
Wednesday, November 9, 2022ASSIGNED TO EXAMINER
Friday, April 8, 2022APPLICATION FILING RECEIPT MAILED
Monday, April 4, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 31, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB